Publication

Wongpalee SP, Vashisht A, Sharma S, Chui D, Wohlschlegel JA, Black DL. 2016. Large-scale remodeling of a repressed exon ribonucleoprotein to an exon definition complex active for splicing. Elife. 5. doi:10.7554/eLife.19743.

Tranesh G, Nassar A. 2016. Metastatic Chordoma: A Diagnostic Challenge on Fine Needle Aspiration. Case Rep Pathol. 2016:2187290. doi:10.1155/2016/2187290.

Lam WY, Becker AM, Kennerly KM, Wong R, Curtis JD, Llufrio EM, McCommis KS, Fahrmann J, Pizzato HA, Nunley RM, et al. 2016. Mitochondrial Pyruvate Import Promotes Long-Term Survival of Antibody-Secreting Plasma Cells. Immunity. 45:60–73. doi:10.1016/j.immuni.2016.06.011.

Tate TH, Baggett B, Rice PFS, Koevary JW, Orsinger GV, Nymeyer AC, Welge WA, Saboda K, Roe DJ, Hatch KD, et al. 2016. Multispectral fluorescence imaging of human ovarian and fallopian tube tissue for early-stage cancer detection. J Biomed Opt. 21:56005. doi:10.1117/1.JBO.21.5.056005.

Sheng J, Wang Y, Turesky RJ, Kluetzman K, Zhang Q-Y, Ding X. 2016. Novel Transgenic Mouse Model for Studying Human Serum Albumin as a Biomarker of Carcinogenic Exposure. Chem Res Toxicol. 29:797–809. doi:10.1021/acs.chemrestox.5b00529.

Strom J, Xu B, Tian X, Chen QM. 2016. Nrf2 protects mitochondrial decay by oxidative stress. FASEB J. 30:66–80. doi:10.1096/fj.14-268904.

Jiralerspong S, Goodwin PJ. 2016. Obesity and Breast Cancer Prognosis: Evidence, Challenges, and Opportunities. J Clin Oncol. 34:4203–4216. doi:10.1200/JCO.2016.68.4480.

Marlowe TA, Lenzo FL, Figel SA, Grapes AT, Cance WG. 2016. Oncogenic Receptor Tyrosine Kinases Directly Phosphorylate Focal Adhesion Kinase (FAK) as a Resistance Mechanism to FAK-Kinase Inhibitors. Mol Cancer Ther. 15:3028–3039. doi:10.1158/1535-7163.MCT-16-0366.

Garcia DO, Lander EM, Wertheim BC, Manson JE, Volpe SL, Chlebowski RT, Stefanick ML, Lessin LS, Kuller LH, Thomson CA. 2016. Pet Ownership and Cancer Risk in the Women’s Health Initiative. Cancer Epidemiol Biomarkers Prev. 25:1311–6. doi:10.1158/1055-9965.EPI-16-0218.

Yao M, Woods C, Lavertu P, Fu P, Gibson M, Rezaee R, Zender C, Wasman J, Sharma N, Machtay M, et al. 2016. Phase II study of erlotinib and docetaxel with concurrent intensity-modulated radiotherapy in locally advanced head and neck squamous cell carcinoma. Head Neck. 38 Suppl 1:E1770–6. doi:10.1002/hed.24313.

Martinez JA, Chalasani P, Thomson CA, Roe D, Altbach M, Galons J-P, Stopeck A, Thompson PA, Villa-Guillen DE, Chow H-HS. 2016. Phase II study of metformin for reduction of obesity-associated breast cancer risk: a randomized controlled trial protocol. BMC Cancer. 16:500. doi:10.1186/s12885-016-2551-3.

Warfel NA, Sainz AG, Song JH, Kraft AS. 2016. PIM Kinase Inhibitors Kill Hypoxic Tumor Cells by Reducing Nrf2 Signaling and Increasing Reactive Oxygen Species. Mol Cancer Ther. 15:1637–47. doi:10.1158/1535-7163.MCT-15-1018.

Stokes J, Hoffman EA, Zeng Y, Larmonier N, Katsanis E. 2016. Post-transplant bendamustine reduces GvHD while preserving GvL in experimental haploidentical bone marrow transplantation. Br J Haematol. 174:102–16. doi:10.1111/bjh.14034.

Patel S, Ragab O, Kamrava M. 2016. Real-time image guidance for gynecologic brachytherapy?. Radiother Oncol. 120:542–543. doi:10.1016/j.radonc.2016.03.018.

Janda J, Burkett NB, Blohm-Mangone K, Huang V, Curiel-Lewandrowski C, Alberts DS, Petricoin EF, Calvert VS, Einspahr J, Dong Z, et al. 2016. Resatorvid-based Pharmacological Antagonism of Cutaneous TLR4 Blocks UV-induced NF-κB and AP-1 Signaling in Keratinocytes and Mouse Skin. Photochem Photobiol. 92:816–825. doi:10.1111/php.12659.

Ruiz, J. M., Hamann, H. H., O’Connor, M. F., & Mehl, M. (2016). The Hispanic Health Paradox: From Epidemiological Phenomenon to Contribution Opportunities for Psychological Science. Group Processes & Intergroup Relations, 19, 462-476. 2016.

Lance P, Thompson PA, Ashbeck EL, Roe DJ, Fales L, Buckmeier J, Wang F, Bhattacharyya A, Hsu C-H, Sherry Chow HH, et al. 2016. Selenium Supplementation for Prevention of Colorectal Adenomas and Risk of Associated Type 2 Diabetes. J Natl Cancer Inst. 108. doi:10.1093/jnci/djw152.

Jandova J, Xu W, Nfonsam V. 2016. Sporadic early-onset colon cancer expresses unique molecular features. J Surg Res. 204:251–60. doi:10.1016/j.jss.2016.04.068.

Akam EA, Tomat E. 2016. Targeting Iron in Colon Cancer via Glycoconjugation of Thiosemicarbazone Prochelators. Bioconjug Chem. 27:1807–12. doi:10.1021/acs.bioconjchem.6b00332.

Harryman WL, Hinton JP, Rubenstein CP, Singh P, Nagle RB, Parker SJ, Knudsen BS, Cress AE. 2016. The Cohesive Metastasis Phenotype in Human Prostate Cancer. Biochim Biophys Acta. 1866:221–231. doi:10.1016/j.bbcan.2016.09.005.

Merchant N, Lyons E, Goff S, Vaughn M, Ware D, Micklos D, Antin P. 2016. The iPlant Collaborative: Cyberinfrastructure for Enabling Data to Discovery for the Life Sciences. PLoS Biol. 14:e1002342. doi:10.1371/journal.pbio.1002342.

Kumar GS, Gokhan E, De Munter S, Bollen M, Vagnarelli P, Peti W, Page R. 2016. The Ki-67 and RepoMan mitotic phosphatases assemble via an identical, yet novel mechanism. Elife. 5. doi:10.7554/eLife.16539.

Cai M, Hruby VJ. 2016. The Melanocortin Receptor System: A Target for Multiple Degenerative Diseases. Curr Protein Pept Sci. 17:488–96. doi:10.2174/1389203717666160226145330.

Khanna A, Lotfi P, Chavan AJ, Montaño NM, Bolourani P, Weeks G, Shen Z, Briggs SP, Pots H, Van Haastert PJM, et al. 2016. The small GTPases Ras and Rap1 bind to and control TORC2 activity. Sci Rep. 6:25823. doi:10.1038/srep25823.

Bhattacharya MRC, Geisler S, Pittman SK, Doan RA, Weihl CC, Milbrandt J, DiAntonio A. 2016. TMEM184b Promotes Axon Degeneration and Neuromuscular Junction Maintenance. J Neurosci. 36:4681–9. doi:10.1523/JNEUROSCI.2893-15.2016.